474 related articles for article (PubMed ID: 29904899)
21. Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis.
Abadie BQ; Cremer PC
BioDrugs; 2022 Jul; 36(4):459-472. PubMed ID: 35639340
[TBL] [Abstract][Full Text] [Related]
22. Rilonacept and Other Interleukin-1 Inhibitors in the Treatment of Recurrent Pericarditis.
Goel A; Bandyopadhyay D; Malik AH; Gupta R; Frishman WH; Aronow WS
Cardiol Rev; 2023 Jul-Aug 01; 31(4):225-229. PubMed ID: 36398320
[TBL] [Abstract][Full Text] [Related]
23. [Pericarditis].
Marques C; Cacoub P
Rev Prat; 2021 Jan; 71(1):79-83. PubMed ID: 34160952
[TBL] [Abstract][Full Text] [Related]
24. [IL-1 antagonists].
Kötter I; Horneff G
Z Rheumatol; 2010 Sep; 69(7):581-93. PubMed ID: 20703489
[TBL] [Abstract][Full Text] [Related]
25. Actual status of antiinterleukin-1 therapies in rheumatic diseases.
Geyer M; Müller-Ladner U
Curr Opin Rheumatol; 2010 May; 22(3):246-51. PubMed ID: 20150813
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of an interleukin-1β receptor antagonist (anakinra) in idiopathic recurrent pericarditis.
Scardapane A; Brucato A; Chiarelli F; Breda L
Pediatr Cardiol; 2013; 34(8):1989-91. PubMed ID: 23052671
[TBL] [Abstract][Full Text] [Related]
27. The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives.
Toplak N; Blazina Š; Avčin T
Drug Des Devel Ther; 2018; 12():1633-1643. PubMed ID: 29922038
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 Blockers for the Treatment of Recurrent Pericarditis: Pathophysiology, Patient-Reported Outcomes, and Perspectives.
Thomas GK; Bonaventura A; Vecchié A; van Tassell B; Imazio M; Klein A; Luis SA; Abbate A
J Cardiovasc Pharmacol; 2024 Jun; 83(6):503-510. PubMed ID: 37163222
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of Interleukin-1 Receptor Antagonists in Patients With Recurrent Pericarditis.
Khayata M; Shah NP; Verma BR; Giugni AS; Alkharabsheh S; Asher CR; Imazio M; Klein AL
Am J Cardiol; 2020 Jul; 127():184-190. PubMed ID: 32416963
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-1 as a therapeutic target in gout.
Dumusc A; So A
Curr Opin Rheumatol; 2015 Mar; 27(2):156-63. PubMed ID: 25633244
[TBL] [Abstract][Full Text] [Related]
31. A novel therapy for an unusual problem: IL-1 receptor antagonist for recurrent post-transplant pericarditis.
Parizo JT; Moayedi Y; Nieman K; Town K; Teuteberg JJ; Khush KK
Clin Transplant; 2019 Oct; 33(10):e13699. PubMed ID: 31437316
[TBL] [Abstract][Full Text] [Related]
32. Pathogenetic mechanisms, new drugs, and old problems in idiopathic recurrent pericarditis: comment on the article by Picco et al.
Brucato A; Imazio M; Spodick D; Adler Y
Arthritis Rheum; 2009 Aug; 60(8):2543; author reply 2543-4. PubMed ID: 19644862
[No Abstract] [Full Text] [Related]
33. Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey.
Rossi-Semerano L; Fautrel B; Wendling D; Hachulla E; Galeotti C; Semerano L; Touitou I; Koné-Paut I;
Orphanet J Rare Dis; 2015 Feb; 10():19. PubMed ID: 25758134
[TBL] [Abstract][Full Text] [Related]
34. New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets.
Xu B; Harb SC; Cremer PC
Curr Cardiol Rep; 2017 Jul; 19(7):60. PubMed ID: 28528454
[TBL] [Abstract][Full Text] [Related]
35. Clinical Trials in Pericardial Disease: New Paradigm Shift.
Imazio M
Curr Cardiol Rep; 2021 Oct; 23(11):170. PubMed ID: 34633515
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 1β: a proinflammatory target for preventing atherosclerotic heart disease.
McCarty S; Frishman W
Cardiol Rev; 2014; 22(4):176-81. PubMed ID: 24618930
[TBL] [Abstract][Full Text] [Related]
37. Anakinra: an emerging option for refractory idiopathic recurrent pericarditis: a systematic review of published evidence.
Lazaros G; Imazio M; Brucato A; Vassilopoulos D; Vasileiou P; Gattorno M; Tousoulis D; Martini A
J Cardiovasc Med (Hagerstown); 2016 Apr; 17(4):256-62. PubMed ID: 26090915
[TBL] [Abstract][Full Text] [Related]
38. Role of interleukin-1 inhibitors in the management of gout.
Tran TH; Pham JT; Shafeeq H; Manigault KR; Arya V
Pharmacotherapy; 2013 Jul; 33(7):744-53. PubMed ID: 23553601
[TBL] [Abstract][Full Text] [Related]
39. Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors.
Lo Presti S; Elajami TK; Reyaldeen R; Anthony C; Imazio M; Klein AL
J Am Heart Assoc; 2021 Oct; 10(19):e021685. PubMed ID: 34569270
[TBL] [Abstract][Full Text] [Related]
40. Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade.
Caorsi R; Insalaco A; Bovis F; Martini G; Cattalini M; Chinali M; Rimini A; Longo C; Federici S; Celani C; Filocamo G; Consolini R; Maggio MC; Fadanelli G; Licciardi F; Romano M; Teruzzi BL; Taddio A; Miniaci A; La Torre F; De Fanti A; Cavalli G; Bigucci B; Gallizzi R; Chinello M; Imazio M; Brucato A; Cimaz R; De Benedetti F; Gattorno M
J Pediatr; 2023 May; 256():18-26.e8. PubMed ID: 36470465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
